Xeris Biopharma Holdings, Inc.

XERS · Healthcare · Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chron…

Xeris Biopharma Holdings, Inc. (XERS), in the Healthcare sector, has 26 disclosed filings on Paydirt over the trailing twelve months from 7 corporate insiders: 0 purchases and 26 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Nov 5 and filed Nov 6. The most active filer was Beth Hecht with 12 filings. Data as of Nov 8 2026.

Add to watchlist

Filings, ttm

0 buys · 26 sells

Traders, ttm

7 insiders

Volume, ttmiDollar value disclosed in the window

$5.2M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Nov 5

Filed Nov 6

ADViAverage daily dollar volume

$16.5M

market data

Share price · 12M

$15.20 (+96.9%)

Adjusted for splits and dividends.

Volume by month

Buys $110K Sells $7.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months

BH Beth Hecht See Remarks 13 filings · 0 buys, 13 sales KM Kevin McCulloch See Remarks 9 filings · 1 buy, 8 sales DH Dawn Halkuff Director 2 filings · 0 buys, 2 sales JJ

John Johnson Director 2 filings · 0 buys, 2 sales JJ John Patrick Shannon Jr See Remarks 2 filings · 0 buys, 2 sales BK Barbara-jean Anne Bormann-kennedy Director 1 filing · 0 buys, 1 sale MP Marla Persky Director 1 filing · 0 buys, 1 sale SP Steven Pieper See Remarks 1 filing · 0 buys, 1 sale

All 9 filers

JS Jeffrey W Sherman Director 1 filing · 0 buys, 1 sale

Recent filings

Kevin McCullochSALE See Remarks $312K
25,000 sh × $12.49
Exec Nov 5
Filed Nov 6 · 4:32 PM ET Beth HechtSALE See Remarks $256K
25,000 sh × $10.23
Exec Nov 2
Filed Nov 4 · 4:57 PM ET Kevin McCullochSALE See Remarks $153K
15,000 sh × $10.23
Exec Nov 2
Filed Nov 4 · 4:57 PM ET Kevin McCullochSALE See Remarks $141K
15,000 sh × $9.41
Exec Oct 1
Filed Oct 2 · 4:54 PM ET Beth HechtSALE See Remarks $157K
16,666 sh × $9.41
Exec Oct 1
Filed Oct 2 · 4:54 PM ET Kevin McCullochSALE See Remarks $250K
25,000 sh × $10.00
Exec Sep 28
Filed Sep 29 · 4:59 PM ET Kevin McCullochSALE See Remarks $127K
15,000 sh × $8.49
Exec Sep 1
Filed Sep 1 · 6:21 PM ET Beth HechtSALE See Remarks $141K
16,666 sh × $8.49
Exec Sep 1
Filed Sep 1 · 6:21 PM ET Kevin McCullochSALE See Remarks $120K
15,000 sh × $8.02
Exec Aug 3
Filed Aug 4 · 5:30 PM ET Beth HechtSALE See Remarks $134K
16,666 sh × $8.01
Exec Aug 3
Filed Aug 4 · 5:16 PM ET Steven PieperSALE See Remarks $383K
45,000 sh across 2 lots
Exec Jul 6
Filed Jul 7 · 5:11 PM ET Kevin McCullochSALE See Remarks $723K
90,000 sh × $8.03
Exec Jul 1
Filed Jul 2 · 4:40 PM ET Beth HechtSALE See Remarks $134K
16,666 sh × $8.03
Exec Jul 1
Filed Jul 2 · 4:38 PM ET Dawn HalkuffSALE Director $122K
20,000 sh × $6.09
Exec Jun 4
Filed Jun 5 · 5:30 PM ET Beth HechtSALE See Remarks $101K
16,667 sh × $6.06
Exec Jun 1
Filed Jun 2 · 5:30 PM ET Beth HechtSALE See Remarks $104K
16,667 sh × $6.23
Exec May 1
Filed May 1 · 5:30 PM ET Beth HechtSALE See Remarks $103K
16,567 sh × $6.24
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Beth HechtSALE See Remarks $124K
16,667 sh × $7.45
Exec Feb 2
Filed Feb 2 · 5:30 PM ET Kevin McCullochSALE See Remarks $120K
15,000 sh × $8.00
Exec Jan 8
Filed Jan 9 · 5:30 PM ET John Patrick Shannon JrSALE See Remarks $176K
24,907 sh × $7.08
Exec Jan 5
Filed Jan 6 · 5:30 PM ET Beth HechtSALE See Remarks $124K
16,667 sh × $7.43
Exec Jan 2
Filed Jan 5 · 5:30 PM ET John JohnsonSALE Director $978K
135,400 sh × $7.22
Exec Dec 19 2025
Filed Dec 19 2025 · 5:30 PM ET Barbara-jean Anne Bormann-kennedySALE Director $106K
15,000 sh × $7.09
Exec Dec 12 2025
Filed Dec 15 2025 · 5:30 PM ET Beth HechtSALE See Remarks $117K
16,667 sh × $7.01
Exec Dec 1 2025
Filed Dec 2 2025 · 5:30 PM ET John Patrick Shannon JrSALE See Remarks $173K
23,242 sh × $7.46
Exec Nov 13 2025
Filed Nov 17 2025 · 5:30 PM ET